Media Library

Design thinking is a sound and viable tool to use as part of an implementation strategy for engaging with health system stakeholders and successfully translating evidence-based practices and new innovations into routine practice, thereby addressing an important knowledge—practice gap and, more broadly, contributing to the strategic repertoire available to implementation science.

Artificial Intelligence in health care offers a way to transform health systems from being reactive to being proactive, predictive, and even preventive. The Novartis Foundation and PATH launched the tool in six countries in 2021 and 2022: Argentina, Brazil, Chile, Philippines, Uruguay, and Vietnam. This white paper shares an overview of the experience these countries had in conducting the self-assessment.

A case study on fostering cardiovascular health at work from Senegal

Hypertension among South African children in disadvantaged areas and associations with physical activity, fitness, and cardiovascular risk markers: A cross-sectional study about Hypertension among South African children in disadvantaged areas

This case study describes how, when faced with an emerging crisis, government officials convened diverse partners to swiftly develop and deploy life-saving AI solutions. The process they undertook provides lessons for developing AI solutions for challenges beyond COVID-19. This initiative operationalized the recommendations from the 2020 Roadmap to AI Maturity from the Broadband Commission for Sustainable Development.

LPEP explored the feasibility of combining three key interventions against leprosy: tracing contacts newly diagnosed patients with leprosy; screening the traced contacts for leprosy; and administering SDR to eligible contacts.

Physical inactivity (PIA) is a growing global health problem and evidence suggests that PIA is a key driver for hypertension, cardiovascular and chronic diseases.

As a result of successful malaria control efforts, Namibia, like many countries in southern Africa, is aiming for elimination by 2020.

The article concludes that a diagnostic test to confirm leprosy disease at an early stage among symptomatic patients would be an acceptable and certainly useful shorter-term compromise.

This study evaluated a 3-year implementation of this CVD program (2016–2019) on the strengthening of local health system and its capacity to better prevent and manage hypertension.